Cabaletta Bio

Cabaletta Bio Forges Ahead: A Strong Year Lays Groundwork for Groundbreaking Autoimmune Disease Therapies

PHILADELPHIA, PA — The biotech company Cabaletta Bio, Inc. (Nasdaq: CABA), known for its pioneering work in autoimmune disease therapeutics, recently announced its financial results and business updates for the …

Cabaletta Bio Forges Ahead: A Strong Year Lays Groundwork for Groundbreaking Autoimmune Disease Therapies Read More


Doctor

Philadelphia College of Osteopathic Medicine and The Wistar Institute Launch Joint Cancer Biology Ph.D. Program

PHILADELPHIA, PA — In a significant advancement for cancer research and medical education, the Philadelphia College of Osteopathic Medicine (PCOM) and The Wistar Institute have announced the creation of a new …

Philadelphia College of Osteopathic Medicine and The Wistar Institute Launch Joint Cancer Biology Ph.D. Program Read More